4.6 Article

Urban Movement and Alcohol Intake Strongly Predict Defaulting from Tuberculosis Treatment: An Operational Study

Journal

PLOS ONE
Volume 7, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0035908

Keywords

-

Funding

  1. Netherlands African Partnership for Clinical Trials and Capacity Building Program (NACCAP)

Ask authors/readers for more resources

Background: High levels of defaulting from treatment challenge tuberculosis control in many African cities. We assessed defaulting from tuberculosis treatment in an African urban setting. Methods: An observational study among adult patients with smear-positive pulmonary tuberculosis receiving treatment at urban primary care clinics in Kampala, Uganda. Defaulting was defined as having missed two consecutive monthly clinic visits while not being reported to have died or continued treatment elsewhere. Defaulting patients were actively followedup and interviewed. We assessed proportions of patients abandoning treatment with and without the information obtained through active follow-up and we examined associated factors through multivariable logistic regression. Results: Between April 2007 and April 2008, 270 adults aged >= 15 years were included; 54 patients (20%) were recorded as treatment defaulters. On active follow-up vital status was established of 28/54 (52%) patients. Of these, 19 (68%) had completely stopped treatment, one (4%) had died and eight (29%) had continued treatment elsewhere. Extrapolating this to all defaulters meant that 14% rather than 20% of all patients had truly abandoned treatment. Daily consumption of alcohol, recorded at the start of treatment, predicted defaulting (adjusted odds ratio [ORadj] 4.4, 95% CI 1.8-13.5), as did change of residence during treatment (ORadj 8.7, 95% CI 1.8-41.5); 32% of patients abandoning treatment had changed residence. Conclusions: A high proportion of tuberculosis patients in primary care clinics in Kampala abandon treatment. Assessing change of residence during scheduled clinic appointments may serve as an early warning signal that the patient may default and needs adherence counseling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

High Rates of Recurrent Tuberculosis Disease: A Population-level Cohort Study

Sabine M. Hermans, Nesbert Zinyakatira, Judy Caldwell, Frank G. J. Cobelens, Andrew Boulle, Robin Wood

Summary: The study found that the rate of recurrent tuberculosis increases with subsequent episodes, regardless of HIV status. HIV infection alone may not explain the high burden of recurrence, suggesting a combination of high infection risk and increased risk associated with previous tuberculosis episodes. High recurrence rates indicate a need for increased tuberculosis surveillance in patients with more than one episode.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Annual Tuberculosis Preventive Therapy for Persons With HIV Infection A Randomized Trial

Gavin Churchyard, Vicky Cardenas, Violet Chihota, Kathy Mngadi, Modulakgotla Sebe, William Brumskine, Neil Martinson, Getnet Yimer, Shu-Hua Wang, Alberto L. Garcia-Basteiro, Dinis Nguenha, LeeAnne Masilela, Zainab Waggie, Susan van den Hof, Salome Charalambous, Frank Cobelens, Richard E. Chaisson, Alison D. Grant, Katherine L. Fielding

Summary: Completion rates were higher with 3 months of rifapentine-isoniazid compared to 6 months of isoniazid, and a second round of preventive therapy did not provide additional benefit to persons receiving antiretroviral therapy in settings with high tuberculosis transmission.

ANNALS OF INTERNAL MEDICINE (2021)

Article Infectious Diseases

An approach for improving the quality of country-level TB modelling

C. F. McQuaid, M. C. Clarkson, M. Bellerose, K. Floyd, R. G. White, N. A. Menzies

Summary: Mathematical modelling is increasingly being used to inform budgeting and strategic decision-making by national TB programmes. A benchmarking, reporting, and review approach has been developed to allow constructive review of country-level TB modelling applications. This approach has been piloted in five modelling applications and has the potential to improve the quality and transparency of country-level TB modelling applications.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)

Letter Public, Environmental & Occupational Health

Tuberculosis and anemia-cause or effect?

Frank Cobelens, Andrew D. Kerkhoff

ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2021)

Article Health Care Sciences & Services

Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis

Everdina W. Tiemersma, Ibrahim Ali, Asnakech Alemu, Yohanna Kambai Avong, Alemayehu Duga, Cassandra Elagbaje, Ambrose Isah, Alexander Kay, Blandina Theophil Mmbaga, Elice Mmari, Kissa Mwamwitwa, Siphesihle Nhlabatsi, Kassech Sintayehu, Aida Arefayne, Mekonnen Teferi, Frank Cobelens, Linda Harmark

Summary: Most countries have necessary laws, regulations and guidelines for pharmacovigilance conducted by the NMRAs. The success of NTP-NMRA collaboration is heavily influenced by interpersonal relationships between staff. The introduction of aDSM has raised awareness among DR-TB healthcare providers.

BMC HEALTH SERVICES RESEARCH (2021)

Article Infectious Diseases

Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV

S. Gatechompol, J. Sophonphan, S. J. Kerr, S. Ubolyam, A. Avihingsanon, F. van Leth, F. Cobelens

Summary: This study evaluated the relationship between multiple time-updated ML ratio measurements and the incidence of TB in PLWH after ART initiation, finding that an increased ML ratio was predictive of incident TB. The ML ratio at a cut point of 0.23 provided a high diagnostic accuracy with a sensitivity of 85% and specificity of 71%.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)

Article Public, Environmental & Occupational Health

Framing the detection of incipient tuberculosis infection: A qualitative study of political prioritisation

Rosemary James, Grant Theron, Frank Cobelens, Nora Engel

Summary: This study explores the current landscape and potential prioritization of diagnosis and treatment of Incipient Tuberculosis (ITB). The implementation of latent TB policies has been slow due to various challenges and framing issues. The authors suggest reframing ITB testing as 'early detection' and management as 'treatment' to increase its importance and acceptance.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2022)

Article Immunology

The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study

Carlotta Fack, Robin Wood, Mark Hatherill, Frank Cobelens, Sabine Hermans

Summary: The change in infant BCG vaccination policy in South Africa was associated with a modest decrease in tuberculosis (TB) incidence in HIV-negative adolescents aged 10 to 17. However, TB incidence rapidly increased during adolescence and remained high despite BCG vaccination at birth.

VACCINE (2022)

Article Microbiology

Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013

Hui Xia, Yang Zheng, Dongxin Liu, Shengfen Wang, WenCong He, Bing Zhao, Yuanyuan Song, Xichao Ou, Yang Zhou, Susan van den Hof, Frank Cobelens, YanLin Zhao

Summary: The study revealed an increase in moxifloxacin resistance among MDR-TB patients in China from 2007 to 2013, suggesting cautious use of the drug in MDR/RR-TB regimens. Laboratory confirmation of susceptibility to moxifloxacin is crucial, given the rise in resistance levels.

MICROBIOLOGY SPECTRUM (2021)

Article Infectious Diseases

Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model

Sivaporn Gatechompol, Jiratchaya Sophonphan, Sasiwimol Ubolyam, Anchalee Avihingsanon, Frank van Leth, Frank Cobelens, Stephen J. Kerr

Summary: This study evaluated the TB incidence among HIV patients receiving long-term ART in Thailand. The findings showed that despite the significant reduction in TB incidence with ART, PLWH still remain at high risk of developing TB. Low CD4 count, underweight, and substance abuse were identified as significant risk factors for incident TB.

BMC INFECTIOUS DISEASES (2022)

Review Infectious Diseases

Accelerating research and development of new vaccines against tuberculosis: a global roadmap

Frank Cobelens, Rajinder Kumar Suri, Michelle Helinski, Michael Makanga, Ana Lucia Weinberg, Britta Schaffmeister, Frank Deege, Mark Hatherill

Summary: In order to eliminate tuberculosis worldwide, there is an urgent need for a new, effective, and affordable vaccine, especially for adults and adolescents in low-income and middle-income countries. A roadmap has been created to accelerate tuberculosis vaccine research and development through a participatory process. The vaccine pipeline needs to incorporate more diverse immunological approaches, antigens, and platforms. Clinical development can be expedited through validated preclinical models, agreed laboratory correlates of protection, efficient trial designs, and validated endpoints. The public health impact of new tuberculosis vaccines can be determined by understanding the demand for them in each country, integrating vaccine implementation with ongoing tuberculosis prevention efforts, considering cost, and stimulating vaccine production on a national and global scale. Investments in tuberculosis vaccine research and development should be increased, with diversification of funding sources and coordination between funders. Open science is crucial for enhancing the efficiency of tuberculosis vaccine research and development, including early and freely available publication of study findings, as well as effective mechanisms for sharing datasets and specimens. Increased engagement of industry vaccine developers, political commitment to new tuberculosis vaccines, and addressing stigma and vaccine hesitancy are also necessary. The rapid development and introduction of COVID-19 vaccines provide valuable insights for tuberculosis vaccine research and development.

LANCET INFECTIOUS DISEASES (2022)

Review Medicine, General & Internal

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?

Ruvandhi R. Nathavitharana, Alberto L. Garcia-Basteiro, Morten Ruhwald, Frank Cobelens, Grant Theron

Summary: Rapid and accurate sputum-free tests for tuberculosis diagnosis are urgently needed. Mid-to-early-stage technologies like AI-based automated digital chest X-radiography and capillary blood point-of-care assays are promising. Challenges include detecting paucibacillary TB and limitations of current reference standards.

EBIOMEDICINE (2022)

Review Respiratory System

End-point definition and trial design to advance tuberculosis vaccine development

Alberto L. Garcia-Basteiro, Richard G. White, Dereck Tait, Alexander C. Schmidt, Molebogeng X. Rangaka, Matthew Quaife, Elisa Nemes, Robin Mogg, Philip C. Hill, Rebecca C. Harris, Willem A. Hanekom, Mike Frick, Andrew Fiore-Gartland, Tom Evans, Alemnew F. Dagnew, Gavin Churchyard, Frank Cobelens, Marcel A. Behr, Mark Hatherill

Summary: Tuberculosis (TB) is a major infectious cause of death globally and there is a urgent need for new and more effective adult and adolescent TB vaccines. The limited funding for vaccine development highlights the importance of efficient trial designs. Prevention of infection (POI) approaches offer an attractive opportunity to accelerate vaccine development, but current tools to measure TB infection end-points are imperfect.

EUROPEAN RESPIRATORY REVIEW (2022)

Article Infectious Diseases

Does BCG vaccination protect against infection with M. tuberculosis?

P. T. Pelzer, Y. Smit, E. W. Tiemersma, N. T. Huong, N. Nhung, F. Cobelens

Summary: This study found no significant association between BCG vaccination and M. tuberculosis infection prevalence in Vietnam, in contrast to similar studies conducted in other countries.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)

Article Immunology

Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007-2017

Hai Viet Nguyen, Hoa Binh Nguyen, Nhung Viet Nguyen, Frank Cobelens, Alyssa Finlay, Cu Huy Dao, Veriko Mirtskhulava, Philippe Glaziou, Huyen T. T. Pham, Petra de Haas, Edine Tiemersma

Summary: The national TB prevalence surveys conducted in Vietnam in 2007 and 2017 showed a 37% decrease in culture-positive TB prevalence and a 53% decrease in smear-positive TB prevalence. This suggests that using molecular methods for primary diagnostics may help improve diagnosis and lower TB burden further.

EMERGING INFECTIOUS DISEASES (2021)

No Data Available